Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 15630-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#15630-1-AP, RRID:AB_2154525
- Product name
- NRD1 antibody
- Antibody type
- Polyclonal
- Description
- NRD1 antibody (Cat. #15630-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse and has been validated for the following applications: IHC, WB,ELISA.
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references LncRNA AC098613.1 promotes acute myeloid leukemia cell differentiation through CDC5L/ADAP1/NRD1 axis.
Serum Nardilysin as a Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma.
Loss of Peripheral Protection in Pancreatic Islets by Proteolysis-Driven Impairment of VTCN1 (B7-H4) Presentation Is Associated with the Development of Autoimmune Diabetes.
Nardilysin-dependent proteolysis of cell-associated VTCN1 (B7-H4) marks type 1 diabetes development.
Jiang Q, Wang X, Yao H, Wang J, Tang P, Liang M, Pan Z, Li B, Lin C, Wu Q, Wang Q, Zheng Q, Kuok CF, Liu H, Sun C, Li D
Apoptosis : an international journal on programmed cell death 2026 Feb 9;31(2):67
Apoptosis : an international journal on programmed cell death 2026 Feb 9;31(2):67
Serum Nardilysin as a Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma.
Xu Y, Xiong Q, Yang Y, Weng N, Li J, Liu J, Yang X, Zeng Z, Zhang Z, Zhu Q
Journal of clinical medicine 2022 May 30;11(11)
Journal of clinical medicine 2022 May 30;11(11)
Loss of Peripheral Protection in Pancreatic Islets by Proteolysis-Driven Impairment of VTCN1 (B7-H4) Presentation Is Associated with the Development of Autoimmune Diabetes.
Radichev IA, Maneva-Radicheva LV, Amatya C, Salehi M, Parker C, Ellefson J, Burn P, Savinov AY
Journal of immunology (Baltimore, Md. : 1950) 2016 Feb 15;196(4):1495-506
Journal of immunology (Baltimore, Md. : 1950) 2016 Feb 15;196(4):1495-506
Nardilysin-dependent proteolysis of cell-associated VTCN1 (B7-H4) marks type 1 diabetes development.
Radichev IA, Maneva-Radicheva LV, Amatya C, Parker C, Ellefson J, Wasserfall C, Atkinson M, Burn P, Savinov AY
Diabetes 2014 Oct;63(10):3470-82
Diabetes 2014 Oct;63(10):3470-82
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- K-562 cells were subjected to SDS PAGE followed by western blot with 15630-1-AP(NRD1 antibody) at dilution of 1:800
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunohistochemical of paraffin-embedded human testis using 15630-1-AP(NRD1 antibody) at dilution of 1:50 (under 10x lens)
- Sample type
- tissue
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The NRD1 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human NRD1. This antibody recognizes human,mouse,rat antigen. The NRD1 antibody has been validated for the following applications: ELISA, WB, IHC analysis.
